Protalix BioTherapeutics
PLX
#8648
Rank
NZ$0.13 B
Marketcap
$1.78
Share price
-4.35%
Change (1 day)
-36.03%
Change (1 year)

Protalix BioTherapeutics (PLX) - Cash on Hand

Cash on Hand as of June 2024 : NZ$72.78 M

According to Protalix BioTherapeutics 's latest financial reports the company has NZ$72.78 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Protalix BioTherapeutics - Cash on Hand chart (from 1999 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$70.46 M101.7%
2022-12-31NZ$34.93 M-38.63%
2021-12-31NZ$56.92 M6.22%
2020-12-31NZ$53.59 M103.2%
2019-12-31NZ$26.37 M-53.18%
2018-12-31NZ$56.33 M-21.8%
2017-12-31NZ$72.04 M-21.14%
2016-12-31NZ$91.35 M-18.23%
2015-12-31NZ$0.11 B60.02%
2014-12-31NZ$69.81 M-33.64%
2013-12-31NZ$0.10 B65.75%
2012-12-31NZ$63.46 M83.46%
2011-12-31NZ$34.59 M-25.95%
2010-12-31NZ$46.72 M-58.55%
2009-12-31NZ$0.11 B52.65%
2008-12-31NZ$73.83 M-7.7%
2007-12-31NZ$79.99 M145.51%
2006-12-31NZ$32.58 M369.75%
2005-12-31NZ$6.93 M777.56%
2004-12-31NZ$0.79 M-29.79%
2003-12-31NZ$1.12 M-27.05%
2002-12-31NZ$1.54 M-30.01%
2001-12-31NZ$2.2 M-39.23%
2000-12-31NZ$3.62 M29.07%
1999-12-31NZ$2.81 M14.9%
1998-12-31NZ$2.44 M159.13%
1997-12-31NZ$0.94 M-12.68%
1996-12-31NZ$1.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.42 B 477.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.67 B 2,207.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.47 B 15,669.84%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.64 B 4,914.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel